This scholarship page was last updated on 25 January 2022. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Department of Health and Human Services National Institutes of Health
Tipo

Research/project funding

Posted on:

Fecha de Cierre:

Expired

Reference Number

RFA-HL-23-011

This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify and characterize potential therapeutic candidates to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and development of therapeutic agents.
Categories: Health.

More Information

Tipo

Research/Project Funding

Posted on:

Fecha de Cierre:

Expired

Reference Number

RFA-HL-23-011

Estados Unidos